Andrew Shering, Legal Representative

Title: Andrew Shering - Innovator in Connective Tissue Engineering

Introduction

Andrew Shering is a notable inventor and legal representative based in Manchester, GB. He has made significant contributions to the field of tissue engineering, particularly in the development of skin equivalents. His innovative approach has the potential to advance medical treatments and improve patient outcomes.

Latest Patents

Andrew holds a patent for a method titled "Skin equivalent culture - Methods of forming soft connective tissue compositions such as skin equivalents, compositions made by the methods and their uses." This patent outlines a comprehensive method for creating connective tissue equivalents. The process involves incubating collagen-producing cells on a support matrix, enhancing collagen production, freeze-drying the construct, and re-populating it with various cell types. This innovative method utilizes fibroblasts and a provisional fibrin matrix, ultimately replacing the matrix with a collagen matrix synthesized in situ by the cells. Andrew's patent represents a significant advancement in the field, with 1 patent to his name.

Career Highlights

Andrew Shering has established himself as a key figure in the field of tissue engineering. His work at Dfb Technology Holdings, LLC has allowed him to focus on innovative solutions for medical applications. His expertise in legal representation complements his inventive pursuits, enabling him to navigate the complexities of patent law effectively.

Collaborations

Andrew collaborates with talented individuals such as Paul Kemp and David Shering. Their combined expertise fosters a creative environment that drives innovation in their projects.

Conclusion

Andrew Shering's contributions to the field of connective tissue engineering exemplify the intersection of innovation and legal expertise. His work continues to pave the way for advancements in medical treatments and regenerative medicine.